Chiral, racemic esters, ethyl (±)-tetrahydrofuran-2-carboxylate
4c, methyl (±)-
-phenylpropionate
9b, methyl (±)-5,5-dimethyl-1,3-thiazolidine-4-carboxylate
12a, 2-methoxyethyl (±)-1-(4-
tert-butylphenyl)-2-oxopyrrolidine-4-carboxylate
15a, (±)-1-benzyloxy-3-chloropropan-2-yl hydrogen succinate
18c, and (±)-3-butyryloxyquinuclidinium butyrate [(±)-
20b·
n-PrCO
2H], areresolved kinetically by enantioselective hydrolysis catalyzed byan
Aspergillus melleus protease [
E = 60; 93.9% ee and 35%yield for (
R)-tetrahydrofuran-2-carboxylic acid
4a], a
Klebsiellaoxytoca hydrolase [
E > 200; 99.5% ee and 36% yield for (
S)-
-phenylpropionic acid
9a], a
K.
oxytoca hydrolase [
E = 145;97.7% ee and 34% yield for (
R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
12b], a
Bacillus brevis protease [
E = 77; 99%ee and 45% yield for (
S)-
15a], a
Serratia marcescence esterase[
E = 49; 99% ee and 43% yield for (
S)-
18c], and an
A.
melleusprotease [
E = 96; 96% ee and 42% yield for (
R)-
20b], respectively. Each enzymatic process is discussed with focus on thefollowing tactical issues: (1) identification of a hydrolase withhigh enantioselectivity, (2) substrate concentrations not less than1 M that allow for industrially viable volume efficiency (space-time yield), (3) product separation by partition between organicand aqueous phases, and (4) alleviation of a hydrolysateinhibiting the enzymatic activity.